CoChat

Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes

Open access
Feinkohl, Insa, Keller, Marketa, Robertson, Christine M., Morling, Joanne R., Williamson, Rachel M., Nee, Lisa D., McLachlan, Stela, Sattar, Naveed, Welsh, Paul, Reynolds, Rebecca M., Russ, Tom C., Deary, Ian J., Strachan, Mark W.J., Price, Jackie F., on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators · 2013 · Diabetes Care

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Macrovascular disease may contribute to increased risk of accelerated cognitive decline in patients with type 2 diabetes. We aimed to determine associations of measures of macrovascular disease with cognitive change in a cognitively healthy older population with type 2 diabetes. RESEARCH DESIGN AND METHODS: Eight hundred thirty-one men and women (aged 60–75 years) attended two waves of the prospective Edinburgh Type 2 Diabetes Study (ET2DS). At baseline, clinical and subclinical macrovascular disease was measured, including cardiovascular event history, carotid intima-media thickness (cIMT), ankle brachial index (ABI), and serum N-terminal probrain natriuretic peptide (NT-proBNP). Seven neuropsychological tests were administered at baseline and after 4 years; scores were combined to a standardized general ability factor (g). Adjustment of follow-up g for baseline g assessed 4-year cognitive change. Adjustment for vocabulary (estimated premorbid ability) was used to estimate lifetime cognitive change. RESULTS: Measures of cognitive decline were significantly associated with stroke, NT-proBNP, ABI, and cIMT, but not with nonstroke vascular events. The association of stroke with increased estimated lifetime cognitive decline (standardized β, −0.12) and of subclinical markers with actual 4-year decline (standardized β, −0.12, 0.12, and −0.15 for NT-proBNP, ABI, and cIMT, respectively) reached the Bonferroni-adjusted level of statistical significance (P < 0.006). Results altered only slightly on adjustment for vascular risk factors. CONCLUSIONS: Stroke and subclinical markers of cardiac stress and generalized atherosclerosis are associated with cognitive decline in older patients with type 2 diabetes. Further investigation into the potential use of subclinical vascular disease markers in predicting cognitive decline is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc12-2241

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Subject participation in the ET2DS.
Figure 1 Subject participation in the ET2DS.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 69

Metadata

Authors
Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., Williamson, R. M., Nee, L. D., McLachlan, S., Sattar, N., Welsh, P., Reynolds, R. M., Russ, T. C., Deary, I. J., Strachan, M. W. J., Price, J. F., & on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators
Affiliations
  • University of Edinburgh (GB)
  • Centre for Population Health Sciences, University of Edinburgh, Edinburgh, Scotland, United Kingdom
  • Western General Hospital (GB)
  • University of Glasgow (GB)
  • The Queen's Medical Research Institute (GB)
  • National Health Service (GB)
Corresponding author
  • Feinkohl, Insa
  • Price, Jackie F.
Venue
Diabetes Care
Published
2013-08-13
Volume
36
Issue
9
Pages
2779-2786
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2169715537
Cited by
69
References
49
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 9 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 5 · 2015: 6 · 2014: 11 · 2013: 3
FWCI
5.90
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders
  • British Heart Foundation (FS/12/62/29889, FS/10/005/28147)
  • Medical Research Council (MR/K026992/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
type 2 diabetes, cognitive decline, macroangiopathy, stroke, carotid intima-media thickness, ankle-brachial index, NT-proBNP, subclinical atherosclerosis, cardiovascular risk, older adults, general intelligence
MeSH terms
Aged, Cognition Disorders, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Prospective Studies, Biomarkers, Stroke, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.